
CymaBay Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
NEWARK, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it… […]